Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
OctoPlus adds staff to senior management
Leiden, Netherlands?OctoPlus, a drug delivery and development company, has promoted Gerben Moolhuizen to chief business officer and appointed Ewoud van Hoogdalem, MD, as chief medical officer.
Leiden, Netherlands-OctoPlus, a drug delivery and development company, has promoted Gerben Moolhuizen to chief business officer and appointed Ewoud van Hoogdalem, MD, as chief medical officer.
Moolhuizen joined the company in 2001 and previously served as its director of OctoPlus Products. He succeeds Henrik Luessen, PhD, who is leaving to start his own consulting company.
Dr. Hoogdalem was director of experimental medicine with Johnson & Johnson Pharmaceutical R&D in Belgium. He is a registered clinical pharmacologist.
Related Videos
Related Content
